NCT01254695

Brief Summary

Faecal incontinence is a devastating condition affecting 2,2 to 5 % of the adult population. The magnitude of the problem is probably underestimated. Sacral nerve stimulation (SNS), has over the last decade given hope to patient failing conservative treatment. Some patient do not have optimal continence after SNS-therapy. This study aims to identify optimal stimulation parameters - that will improve the functional outcome of SNS-therapy thru a double blinded randomized cross-over study.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2010

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 6, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

November 10, 2011

Status Verified

November 1, 2011

Enrollment Period

8 months

First QC Date

December 3, 2010

Last Update Submit

November 9, 2011

Conditions

Keywords

Idiopathic Fecal IncontinenceFecal IncontinenceSacral Nerve StimulationSacral Nerve Neuromodulation

Outcome Measures

Primary Outcomes (1)

  • Quality of life changes

    Quality of life will be recorded by means of Rockwood faecal incontinence quality of life score. A total of five evaluations will be made every fourth week in the twenty week protocol perioed.

    Will be assessed every four weeks during a twenty-week period

Secondary Outcomes (6)

  • Number of incontinence episodes

    Will be assessed every four weeks durring a twenty-week period

  • Days with faecal soiling

    Will be assessed every four weeks during a twenty-week period

  • Days with faecal urgency.

    Will be assessed every four weeks during a twelve-week period

  • Wexner incontinence score

    Will be assessed every four weeks during a twenty-week period

  • St. Marks Incontinence score

    Will be assessed every four weeks during a twenty-week period

  • +1 more secondary outcomes

Study Arms (5)

Standard settings

ACTIVE COMPARATOR

Amplitude: Sensory threshold Frequency:14 Hz Pulse width 210 μsec

Device: Medtronic InterStim / InterStim II

Experimental Setting 1

EXPERIMENTAL

Amplitude: Sensory threshold Frequency:6.9 Hz Pulse width 210 μsec

Device: Medtronic InterStim / InterStim II

Experimental setting 2

EXPERIMENTAL

Amplitude: Sensory threshold Frequency:31 Hz Pulse width 210 μsec

Device: Medtronic InterStim / InterStim II

Experimental setting 3

EXPERIMENTAL

Amplitude: Sensory threshold Frequency:14 Hz Pulse width 330 μsec

Device: Medtronic InterStim / InterStim II

Experimental setting 4

EXPERIMENTAL

Amplitude: Sensory threshold Frequency:14 Hz Pulse width 90 μsec

Device: Medtronic InterStim / InterStim II

Interventions

Standard stimulation (Amplitude: sensory threshold, frequency 14 Hz, Pulsewidth 210 microsec.) will be compared wiht experimental setting 1,2,3,4

Also known as: Medtronic InterStim, Medtronic InterStim II
Experimental Setting 1Experimental setting 2Experimental setting 3Experimental setting 4Standard settings

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed Consent
  • Diagnosed with idiopathic faecal incontinence,incontinence with minor (≤60 degrees) sphincteric defects or incontinence following sphincter repair.
  • Medtronic Interstim IPG(pacemaker)implanted for more than 6 months
  • minimum one incontinence episodes pr. week during ongoing SNS-therapy

You may not qualify if:

  • Colorectal surgery after IPG-implantation
  • Pregnancy or breastfeeding
  • Anal/perianal pain or discomfort
  • Patients who are not deemed able to follow the planned testing program, including mental illness or mentally unstable patients
  • Medication with known effects on gastrointestinal motility, thyroid disease, diabetes, coeliac, neurological disorders.
  • Spinal cord injury
  • Irritable Bowel Syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Anal Physiology Laboratory, Surgical Research Section 900, Aarhus University Hospital

Aarhus, Aarhus C, 8200, Denmark

Location

St. Marks Hospital

London, Harrow - Middlesex, HA1 3UJ, United Kingdom

Location

Related Publications (1)

  • Duelund-Jakobsen J, Dudding T, Bradshaw E, Buntzen S, Lundby L, Laurberg S, Vaizey C. Randomized double-blind crossover study of alternative stimulator settings in sacral nerve stimulation for faecal incontinence. Br J Surg. 2012 Oct;99(10):1445-52. doi: 10.1002/bjs.8867.

MeSH Terms

Conditions

Fecal Incontinence

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Jakob k Jakobsen, MD.

    Anal Physiology Laboratory, Surgical Research Section 900, Aarhus University Hospital, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2010

First Posted

December 6, 2010

Study Start

July 1, 2010

Primary Completion

March 1, 2011

Study Completion

June 1, 2011

Last Updated

November 10, 2011

Record last verified: 2011-11

Locations